Niagen Bioscience (NAGE) Other Non-Current Assets (2011 - 2026)
Niagen Bioscience's (NAGE) quarterly Other Non-Current Assets came in at $406000.0 in Q1 2026, up 167.11% year-on-year from $152000.0 in Q1 2025, and down 4.47% on a QoQ basis from $425000.0 in Q4 2025.
Niagen Bioscience (NAGE) Other Non-Current Assets (2011 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has 14 years of Other Non-Current Assets data on file, last reported at $406000.0 in Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 167.11% year-over-year to $406000.0 in Q1 2026; TTM through Mar 2026 was $406000.0, a 167.11% increase from a year earlier, with the FY2025 full-year figure at $425000.0, up 179.61% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $406000.0, down from $425000.0 in the prior quarter.
- Over the last five years, Other Non-Current Assets for NAGE reached as high as $425000.0 in Q4 2025 and fell as low as $152000.0 in Q1 2022.
- Historically, Other Non-Current Assets has averaged $213470.6 across 5 years, with a median of $152000.0 in 2022.
- Across the five-year window, Other Non-Current Assets dropped 24.0% in 2022 and soared 179.61% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $152000.0 in 2022, then changed by 0.0% to $152000.0 in 2023, then changed by 0.0% to $152000.0 in 2024, then surged by 179.61% to $425000.0 in 2025, then retreated by 4.47% to $406000.0 in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $406000.0 in Q1 2026, $425000.0 in Q4 2025, and $417000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Niagen Bioscience | 253.47 Mn | 186.92 Mn | 19.98 Mn | 406,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 406,000.00 |
| Dec 31, 2025 | 425,000.00 |
| Sep 30, 2025 | 417,000.00 |
| Jun 30, 2025 | 405,000.00 |
| Mar 31, 2025 | 152,000.00 |
| Dec 31, 2024 | 152,000.00 |
| Sep 30, 2024 | 152,000.00 |
| Jun 30, 2024 | 152,000.00 |
| Mar 31, 2024 | 152,000.00 |
| Dec 31, 2023 | 152,000.00 |
| Sep 30, 2023 | 152,000.00 |
| Jun 30, 2023 | 152,000.00 |
| Mar 31, 2023 | 152,000.00 |
| Dec 31, 2022 | 152,000.00 |
| Sep 30, 2022 | 152,000.00 |
| Jun 30, 2022 | 152,000.00 |
| Mar 31, 2022 | 152,000.00 |
| Dec 31, 2021 | 152,000.00 |
| Sep 30, 2021 | 200,000.00 |
| Jun 30, 2021 | 200,000.00 |